References
Abboud, R., Keller, J., Slade, M., DiPersio, J.F., Westervelt, P., Rettig, M. P., Meier, S., Fehniger, T.A., Abboud, C.N., Uy, G.L., et al. (2016). Severe cytokine-release syndrome after T cell-replete peripheral blood haploidentical donor transplantation is associated with poor survival and anti-IL-6 therapy is safe and well tolerated. Biol Blood Marrow Transplant 22, 1851–1860.
Chang, Y.J., and Huang, X.J. (2016). Haploidentical stem cell transplantation: anti-thymocyte globulin-based experience. Semin Hematol 53, 82–89.
Clay, J., Kulasekararaj, A.G., Potter, V., Grimaldi, F., McLornan, D., Raj, K., de Lavallade, H., Kenyon, M., Pagliuca, A., Mufti, G.J., et al. (2014). Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia. Biol Blood Marrow Transplant 20, 1711–1716.
DeZern, A.E., Zahurak, M., Symons, H., Cooke, K., Jones, R.J., and Brodsky, R.A. (2017). Alternative donor transplantation with high-dose post-transplantation cyclophosphamide for refractory severe aplastic anemia. Biol Blood Marrow Transplant 23, 498–504.
Kanakry, C.G., Coffey, D.G., Towlerton, A.M.H., Vulic, A., Storer, B.E., Chou, J., Yeung, C.C.S., Gocke, C.D., Robins, H.S., O’Donnell, P.V., et al. (2016). Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide. JCI Insight 1.
Liu, Y., Huang, X., Fei, Q., Xu, L., Zhang, X., Liu, K., Chen, Y., Chen, H., and Wang, Y. (2019). Comparison analysis between haplo identical stem cell transplantation and matched sibling donor stem cell transplantation for high-risk acute myeloid leukemia in first complete remission. Sci China Life Sci 62, 691–697.
Luznik, L., Jones, R.J., and Fuchs, E.J. (2010). High-dose cyclophosphamide for graft-versus-host disease prevention. Curr Opin Hematol 17, 493–499.
Rashidi, A., Slade, M., DiPersio, J.F., Westervelt, P., Vij, R., and Romee, R. (2016). Post-transplant high-dose cyclophosphamide after HLA-matched vs haploidentical hematopoietic cell transplantation for AML. Bone Marrow Transplant 51, 1561–1564.
Rubio, M.T., Savani, B.N., Labopin, M., Piemontese, S., Polge, E., Ciceri, F., Bacigalupo, A., Arcese, W., Koc, Y., Beelen, D., et al. (2016). Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT. J Hematol Oncol 9, 25.
Xu, L.P., **, S., Wang, S.Q., **a, L.H., Bai, H., Gao, S.J., Liu, Q.F., Wang, J.M., Wang, X., Jiang, M., et al. (2017). Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol 10, 25.